Glucose [161] and other carbohydrates such as d-allulose [162], Astragalus polysaccharide (APS) [163], polysaccharides from Dendrobium officinale [164], indigestible polysaccharides resistant maltodextrin (RMD) [165], -glucan or arabinoxylan [166], and enzymatically-synthesized glycogen [167]stimulate GLP-1 secretion by utilizing glucose sensors, including sweet taste receptors (STRs), sodium-glucose transporter 1 (SGLT-1), and monosaccharide transporter [168, 169] (Fig
There are also GLP-1 medications produced by compounding pharmacies, which use tirzepatide, semaglutide, or another GLP-1 receptor agonist
Because the benefits of intensive glucose control emerge slowly while the harms can be immediate, people with longer life expectancy have more to gain from early intensive glycaemic management
Additionally, the weight loss achieved with these medications often leads to improved self-esteem, body image, and physical functioning, all of which can positively influence mood
Visit TeleMedsForMe to find trusted, convenient telehealth providers who can help you get started.
The effectiveness of the matching was evaluated using the Standardized Mean Difference (SMD), with an SMD value of less than 0.1 indicating a negligible difference between the groups, thus affirming the efficacy of the matching process
